Risk of bleeding and use of platelet transfusions in patients with hematologic malignancies: recurrent event analysis

Affiliations

Simon J. Stanworth: NHS Blood and Transplant/Oxford University Hospitals NHS Trust, John Radcliffe Hospital, Oxford, UK; Radcliffe Department of Medicine, University of Oxford, UK
Cara L. Hudson: Statistics and Clinical Studies, NHS Blood and Transplant, Bristol, UK
Lise J. Estcourt: NHS Blood and Transplant/Oxford University Hospitals NHS Trust, John Radcliffe Hospital, Oxford, UK; Radcliffe Department of Medicine, University of Oxford, UK
Rachel J. Johnson: Statistics and Clinical Studies, NHS Blood and Transplant, Bristol, UK
Erica M. Wood: Transfusion Research Unit, Monash University, Melbourne, Australia

Abstract

A recent randomized trial (TOPPS) compared prophylactic platelet transfusions (for counts

ISSN: 0390-6078 (Print); 1592-8721 (Online)
Publisher: Ferrata Storti Foundation
Country of publisher: Italy
LCC subjects: Medicine: Internal medicine: Specialties of internal medicine: Diseases of the blood and blood-forming organs
Website: http://www.haematologica.org